首页 > 最新文献

Pharmacy Practice-Granada最新文献

英文 中文
The influence of SARS-COV-2 pandemic in the pharmaceutical service in ALBANIA. 严重急性呼吸系统综合征冠状病毒2型疫情对阿尔巴尼亚制药服务的影响。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-12-21 DOI: 10.18549/PharmPract.2023.1.2750
Irsida Mehmeti, Silvi Bozo, Entela Kostrista, Eftiola Pojani

Objective: In the second year of the COVID-19 pandemic, the role of the pharmacists was confirmed as central at the territorial level. The purpose of this study was to assess knowledge, attitudes, and practices of pharmacists in Albania, critical changes in the Albanian pharmaceutical market during the COVID-19 pandemic and evaluate factors influencing the quality of the pharmaceutical service.

Methods: A nationwide survey was conducted, using an online questionnaire targeting Albanian pharmacists during 2021.

Results: Most of the respondents were females (86.2%), belonged to the 30-39 age group (51.7%) and worked in community pharmacies (73%). Although most of the respondents did participate in training courses (62.8%), only about 38% of them had good knowledge about COVID-19 (score 5/8). Moreover, the level of knowledge increases the possibility to apply the rules. 65% of the pharmacists who were very afraid of getting infected with COVID -19, stated that they followed the WHO rules compared to 37 % of those who were not afraid. Regarding the medicines offered, 64% of the respondents claimed that there have been difficulties in ensuring the adequate medicines during the pandemic. Furthermore, although 61% of the pharmacists declared that the price of medicines during the pandemic has not changed, 58% of them thought that the revenues of all pharmaceutical sectors have risen.

Conclusion: From this study it is concluded that although the pharmacists in Albania have demonstrated strength, professionality, and commitment to offer pharmaceutical service to the highest level, they faced numerous challenges during this difficult time. In the future, the pharmacist's role can be extended in the community to provide successful medical service and their collaboration within and between pharmacists and physicians is essential.

目的:在新冠肺炎大流行的第二年,药剂师的作用被确认为地区层面的中心。本研究的目的是评估阿尔巴尼亚药剂师的知识、态度和实践,以及新冠肺炎大流行期间阿尔巴尼亚药品市场的关键变化,并评估影响药品服务质量的因素。方法:在2021年期间,使用针对阿尔巴尼亚药剂师的在线问卷进行了一项全国性调查。结果:大多数受访者是女性(86.2%),属于30-39岁年龄组(51.7%),在社区药房工作(73%)。尽管大多数受访者确实参加了培训课程(62.8%),但只有约38%的受访者对新冠肺炎有很好的了解(得分5/8)。此外,知识水平增加了应用规则的可能性。65%非常害怕感染COVID-19的药剂师表示,他们遵守了世界卫生组织的规定,而不害怕的药剂师只有37%。关于提供的药物,64%的受访者声称,在疫情期间,难以确保足够的药物。此外,尽管61%的药剂师宣称疫情期间的药品价格没有变化,但58%的药剂师认为所有制药部门的收入都有所上涨。结论:根据这项研究得出的结论是,尽管阿尔巴尼亚的药剂师表现出了实力、专业性和提供最高水平药物服务的承诺,但他们在这段困难时期面临着许多挑战。未来,药剂师的作用可以在社区中扩大,以提供成功的医疗服务,药剂师和医生之间的合作至关重要。
{"title":"The influence of SARS-COV-2 pandemic in the pharmaceutical service in ALBANIA.","authors":"Irsida Mehmeti,&nbsp;Silvi Bozo,&nbsp;Entela Kostrista,&nbsp;Eftiola Pojani","doi":"10.18549/PharmPract.2023.1.2750","DOIUrl":"10.18549/PharmPract.2023.1.2750","url":null,"abstract":"<p><strong>Objective: </strong>In the second year of the COVID-19 pandemic, the role of the pharmacists was confirmed as central at the territorial level. The purpose of this study was to assess knowledge, attitudes, and practices of pharmacists in Albania, critical changes in the Albanian pharmaceutical market during the COVID-19 pandemic and evaluate factors influencing the quality of the pharmaceutical service.</p><p><strong>Methods: </strong>A nationwide survey was conducted, using an online questionnaire targeting Albanian pharmacists during 2021.</p><p><strong>Results: </strong>Most of the respondents were females (86.2%), belonged to the 30-39 age group (51.7%) and worked in community pharmacies (73%). Although most of the respondents did participate in training courses (62.8%), only about 38% of them had good knowledge about COVID-19 (score 5/8). Moreover, the level of knowledge increases the possibility to apply the rules. 65% of the pharmacists who were very afraid of getting infected with COVID -19, stated that they followed the WHO rules compared to 37 % of those who were not afraid. Regarding the medicines offered, 64% of the respondents claimed that there have been difficulties in ensuring the adequate medicines during the pandemic. Furthermore, although 61% of the pharmacists declared that the price of medicines during the pandemic has not changed, 58% of them thought that the revenues of all pharmaceutical sectors have risen.</p><p><strong>Conclusion: </strong>From this study it is concluded that although the pharmacists in Albania have demonstrated strength, professionality, and commitment to offer pharmaceutical service to the highest level, they faced numerous challenges during this difficult time. In the future, the pharmacist's role can be extended in the community to provide successful medical service and their collaboration within and between pharmacists and physicians is essential.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2750"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/74/pharmpract-21-2750.PMC10117356.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease. 评估免疫细胞比率和炎症标志物在炎症性肠病诊断中的临床应用。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-11-08 DOI: 10.18549/PharmPract.2023.1.2755
Mamoon M D Al-Rshaidat, Shaima Al-Sharif, Assem Al Refaei, Nour Shewaikani, Ahmad R Alsayed, Yaser M Rayyan

Objective: Inflammatory Bowel Diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract, including Crohn's disease (CD) and ulcerative colitis (UC). Developing methods for effective screening and diagnosis is extremely needed. Accordingly, this study aims to evaluate the potential of immune cells ratios in the diagnosis of IBD.

Methods: This case-control study includes data from Jordan University Hospital (JUH) medical records for IBD patients with age- and gender-matched healthy controls.

Results: This study included 46 participants, of which 56.52% had IBD, 54.35% were males, with insignificant differences in sex, age, and body mass index (BMI) between IBD patients and controls (p>0.05). In the CD group, the variables with the highest sensitivity and specificity (HSS) were neutrophil-to-lymphocyte (NLR) (75%, 80%) and platelet-to-lymphocytes (PLR) (75%, 90%), in UC group; mean corpuscular hemoglobin (MCH) (80%, 80%). In CD group, the combinations giving the HSS were PLR+NLR (76%, 90.9%), C-reactive protein (CRP)+PLR (76%, 90.9%), and CRP+NLR (73.07%, 90%). In UC group, the combinations giving the HSS were erythrocyte sedimentation rate (ESR)+PLR (76.9%, 100%), PLR+MCH (74.07%, 100%), PLR+CRP (71.42%, 100%), and PLR+NLR (71.42%, 100%). Regression analysis identified five different combinations of significance in the diagnosis of CD and UC. Higher Youden's index was used and defined the most beneficial clinical combinations as NLR+PLR and CRP+PLR for CD, whereas ESR+PLR for UC.

Conclusion: Implications to our study include the clinical application of immune cell ratios, inflammatory markers, and their different combinations along with patients' history and physical examination findings for easier, faster, and more cost-effective diagnosis of IBDs.

目的:炎症性肠病(IBDs)是胃肠道的慢性炎症性疾病,包括克罗恩病(CD)和溃疡性结肠炎(UC)。迫切需要开发有效的筛查和诊断方法。因此,本研究旨在评估免疫细胞比率在IBD诊断中的潜力。方法:本病例对照研究包括约旦大学医院(JUH)对年龄和性别匹配的健康对照IBD患者的医疗记录数据。结果:本研究包括46名参与者,其中56.52%患有IBD,54.35%为男性,IBD患者与对照组在性别、年龄和体重指数(BMI)方面差异不显著(p>0.05);平均红细胞血红蛋白(MCH)(80%、80%)。在CD组中,给予HSS的组合为PLR+NLR(76%,90.9%)、C反应蛋白(CRP)+PLR(76%,90.09%)和CRP+NLR(73.07%,90%)。UC组给予HSS的组合为红细胞沉降率(ESR)+PLR(76.9%,100%)、PLR+MCH(74.07%,100%),PLR+CRP(71.42%,100%)和PLR+NLR(71.42%、100%)。回归分析确定了CD和UC诊断中五种不同的显著性组合。使用了更高的尤登指数,并将最有益的临床组合定义为CD的NLR+PLR和CRP+PLR,而UC的ESR+PLR。结论:对我们研究的意义包括免疫细胞比率、炎症标志物及其不同组合的临床应用,以及患者的病史和体检结果,以及更具成本效益的IBD诊断。
{"title":"Evaluating the clinical application of the immune cells' ratios and inflammatory markers in the diagnosis of inflammatory bowel disease.","authors":"Mamoon M D Al-Rshaidat,&nbsp;Shaima Al-Sharif,&nbsp;Assem Al Refaei,&nbsp;Nour Shewaikani,&nbsp;Ahmad R Alsayed,&nbsp;Yaser M Rayyan","doi":"10.18549/PharmPract.2023.1.2755","DOIUrl":"10.18549/PharmPract.2023.1.2755","url":null,"abstract":"<p><strong>Objective: </strong>Inflammatory Bowel Diseases (IBDs) are chronic inflammatory conditions of the gastrointestinal tract, including Crohn's disease (CD) and ulcerative colitis (UC). Developing methods for effective screening and diagnosis is extremely needed. Accordingly, this study aims to evaluate the potential of immune cells ratios in the diagnosis of IBD.</p><p><strong>Methods: </strong>This case-control study includes data from Jordan University Hospital (JUH) medical records for IBD patients with age- and gender-matched healthy controls.</p><p><strong>Results: </strong>This study included 46 participants, of which 56.52% had IBD, 54.35% were males, with insignificant differences in sex, age, and body mass index (BMI) between IBD patients and controls (p>0.05). In the CD group, the variables with the highest sensitivity and specificity (HSS) were neutrophil-to-lymphocyte (NLR) (75%, 80%) and platelet-to-lymphocytes (PLR) (75%, 90%), in UC group; mean corpuscular hemoglobin (MCH) (80%, 80%). In CD group, the combinations giving the HSS were PLR+NLR (76%, 90.9%), C-reactive protein (CRP)+PLR (76%, 90.9%), and CRP+NLR (73.07%, 90%). In UC group, the combinations giving the HSS were erythrocyte sedimentation rate (ESR)+PLR (76.9%, 100%), PLR+MCH (74.07%, 100%), PLR+CRP (71.42%, 100%), and PLR+NLR (71.42%, 100%). Regression analysis identified five different combinations of significance in the diagnosis of CD and UC. Higher Youden's index was used and defined the most beneficial clinical combinations as NLR+PLR and CRP+PLR for CD, whereas ESR+PLR for UC.</p><p><strong>Conclusion: </strong>Implications to our study include the clinical application of immune cell ratios, inflammatory markers, and their different combinations along with patients' history and physical examination findings for easier, faster, and more cost-effective diagnosis of IBDs.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2755"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7a/d3/pharmpract-21-2755.PMC10117338.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The effects and safety of high dose vitamin D3 in hemodialysis patients. 高剂量维生素D3在血液透析患者中的疗效和安全性。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-01-05 DOI: 10.18549/PharmPract.2023.1.2773
Adnane Guella, Abduelmula R Abduelkarem, Mohammed M Hassanein

Background: Different studies have shown that hemodialysis patients require higher doses of Vitamin D3 (VD3) than the general population to achieve satisfactory replenishment. This study aims to assess the safety of such practice and its benefits on some of the parameters of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD).

Methods: A single-center clinical trial assessing the benefits of high dose VD3 in hemodialysis patients. The dose of VD3 (300,000 IU) was administered orally and monthly from April to December 2020 (9 months) at the dialysis unit. The data analyzed were blood levels of calcium, phosphorus, alkaline phosphatase, 25(OH)D, 1,25(OH)2D and intact parathyroid hormone (iPTH) done every three months.

Results: We could recruit a cohort of 23 patients. Blood levels of 25(OH)D increased significantly in 82.6% of the patients to above 30 ng/ml. A similar effect was observed with 1, 25(OH)2D levels. iPTH levels decreased significantly when levels of 25(OH)D exceeded 30ng/ml at the end of the nine months. Vitamin D serum levels were typically measured immediately before the next monthly dose was administered. Blood levels of calcium, phosphorus, and alkaline phosphatase were stable during the study period. No events of hypercalcemia were reported, and no patient discontinued the monthly VD3 supplementation.

Conclusion: Monthly administration of a high dose of VD3 over a long period of nine months in hemodialysis patients was found to be safe and beneficial in VD3 replenishment. It also allowed a significant decrease in iPTH levels. Further studies are warranted to identify the therapeutic target level of 25(OH)D in hemodialysis patients, allowing beneficial effects on iPTH.

背景:不同的研究表明,血液透析患者需要比普通人群更高剂量的维生素D3(VD3)才能获得满意的补充。本研究旨在评估这种做法的安全性及其对慢性肾脏疾病-矿物质和骨骼障碍(CKD-MBD)的一些参数的益处。方法:一项评估高剂量VD3对血液透析患者益处的单中心临床试验。VD3剂量(300000 IU)于2020年4月至12月(9个月)在透析室口服和每月给药。分析的数据是每三个月进行一次的钙、磷、碱性磷酸酶、25(OH)D、1,25(OH)2D和完整甲状旁腺激素(iPTH)的血液水平。结果:我们可以招募23名患者。82.6%的患者血液中25(OH)D水平显著升高至30 ng/ml以上。在1.25(OH)2D水平下观察到类似的效果。当25(OH)D的水平在9个月结束时超过30ng/ml时,iPTH水平显著降低。维生素D血清水平通常在下一个月给药前立即测量。在研究期间,血液中钙、磷和碱性磷酸酶的水平是稳定的。无高钙血症事件报告,也无患者停止每月补充VD3。结论:血液透析患者在9个月的长时间内每月给予高剂量VD3是安全有益的。它还允许iPTH水平显著下降。需要进一步的研究来确定血液透析患者25(OH)D的治疗目标水平,从而对iPTH产生有益影响。
{"title":"The effects and safety of high dose vitamin D3 in hemodialysis patients.","authors":"Adnane Guella,&nbsp;Abduelmula R Abduelkarem,&nbsp;Mohammed M Hassanein","doi":"10.18549/PharmPract.2023.1.2773","DOIUrl":"10.18549/PharmPract.2023.1.2773","url":null,"abstract":"<p><strong>Background: </strong>Different studies have shown that hemodialysis patients require higher doses of Vitamin D3 (VD3) than the general population to achieve satisfactory replenishment. This study aims to assess the safety of such practice and its benefits on some of the parameters of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD).</p><p><strong>Methods: </strong>A single-center clinical trial assessing the benefits of high dose VD3 in hemodialysis patients. The dose of VD3 (300,000 IU) was administered orally and monthly from April to December 2020 (9 months) at the dialysis unit. The data analyzed were blood levels of calcium, phosphorus, alkaline phosphatase, 25(OH)D, 1,25(OH)2D and intact parathyroid hormone (iPTH) done every three months.</p><p><strong>Results: </strong>We could recruit a cohort of 23 patients. Blood levels of 25(OH)D increased significantly in 82.6% of the patients to above 30 ng/ml. A similar effect was observed with 1, 25(OH)2D levels. iPTH levels decreased significantly when levels of 25(OH)D exceeded 30ng/ml at the end of the nine months. Vitamin D serum levels were typically measured immediately before the next monthly dose was administered. Blood levels of calcium, phosphorus, and alkaline phosphatase were stable during the study period. No events of hypercalcemia were reported, and no patient discontinued the monthly VD3 supplementation.</p><p><strong>Conclusion: </strong>Monthly administration of a high dose of VD3 over a long period of nine months in hemodialysis patients was found to be safe and beneficial in VD3 replenishment. It also allowed a significant decrease in iPTH levels. Further studies are warranted to identify the therapeutic target level of 25(OH)D in hemodialysis patients, allowing beneficial effects on iPTH.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2773"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2d/32/pharmpract-21-2773.PMC10117363.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perception and attitudes toward COVID- 19 vaccines in Jordan: lessons for future pandemics. 约旦对COVID-19疫苗的看法和态度:未来流行病的教训。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-12-21 DOI: 10.18549/PharmPract.2023.1.2781
Dalal Alnatour, Razan I Nassar, Yara Salhi, Samar Thiab, Ahmad R Alsayed

Objective: This study aimed to assess Jordanians' perception and attitudes toward COVID-19 vaccines authorized for use in Jordan. Another objective was to evaluate the population's confidence in vaccine efficacy, their fears of the vaccines, and their perceptions and attitudes after vaccination.

Methods: This cross-sectional study was conducted over four months (August 2021- December 2021) and included the general Jordanian population above 18 years old.

Results: A total of 398 participants were included in the study, with the majority (around 81.0%) received at least one dose of any of COVID-19 vaccines approved for use in Jordan. Most non-vaccinated participants (67.4%) were either unwilling to receive the COVID-19 vaccine or unsure. The main reasons for receiving the vaccine were: family protection, self-protection, global efforts to fight the virus and local restrictions, with some variability between vaccinated and non-vaccinated. The major reasons for fear of COVID-19 vaccines were limited research, vaccine effectiveness, and vaccine side effects. Pfizer-BioNTech vaccine was the most trusted vaccine by vaccinated and non-vaccinated participants (47.8% and 57.9%, respectively), and Oxford-AstraZeneca was the most feared by them (42.2% and 57.9%, respectively). Internet websites (>85.0%), social media platforms (>70.0%), relatives and friends (>69.0%), and news applications (>60.0%) were the major sources of information about the COVID-19 vaccines among participants.

Conclusion: Our results revealed that hesitation in receiving the vaccine remains a challenge in Jordan, as in other countries. The findings also show that participants, regardless of their vaccination status, had many concerns about the four types of vaccines approved for use in Jordan during the study conduction period. Moreover, the participants' perceptions and attitudes towards the vaccines were variable between vaccinated and non-vaccinated participants and were variable for the four types of vaccines.

目的:本研究旨在评估约旦人对获准在约旦使用的新冠肺炎疫苗的认知和态度。另一个目标是评估人群对疫苗效力的信心、他们对疫苗的恐惧以及他们接种疫苗后的看法和态度。方法:这项横断面研究历时四个月(2021年8月至2021年12月),包括18岁以上的约旦普通人群。结果:共有398名参与者参与了这项研究,其中大多数(约81.0%)至少接种了一剂获准在约旦使用的新冠肺炎疫苗。大多数未接种疫苗的参与者(67.4%)要么不愿意接种新冠肺炎疫苗,要么不确定。接种疫苗的主要原因是:家庭保护、自我保护、全球抗击病毒的努力和当地的限制,接种疫苗和未接种疫苗之间存在一些差异。对新冠肺炎疫苗感到恐惧的主要原因是研究有限、疫苗有效性和疫苗副作用。辉瑞-BioNTech疫苗是接种疫苗和未接种疫苗的参与者最信任的疫苗(分别为47.8%和57.9%),而牛津-阿斯利康疫苗是他们最害怕的(分别为42.2%和57.9%。互联网网站(>85.0%)、社交媒体平台(>70.0%)、亲友(>69.0%)和新闻应用程序(>60.0%)是参与者中有关新冠肺炎疫苗的主要信息来源。结论:我们的研究结果表明,与其他国家一样,在约旦,接种疫苗的犹豫仍然是一个挑战。研究结果还表明,在研究进行期间,无论参与者的疫苗接种状况如何,他们都对约旦批准使用的四种疫苗有很多担忧。此外,参与者对疫苗的看法和态度在接种疫苗和未接种疫苗的参与者之间是可变的,并且在四种类型的疫苗中也是可变的。
{"title":"Perception and attitudes toward COVID- 19 vaccines in Jordan: lessons for future pandemics.","authors":"Dalal Alnatour,&nbsp;Razan I Nassar,&nbsp;Yara Salhi,&nbsp;Samar Thiab,&nbsp;Ahmad R Alsayed","doi":"10.18549/PharmPract.2023.1.2781","DOIUrl":"10.18549/PharmPract.2023.1.2781","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess Jordanians' perception and attitudes toward COVID-19 vaccines authorized for use in Jordan. Another objective was to evaluate the population's confidence in vaccine efficacy, their fears of the vaccines, and their perceptions and attitudes after vaccination.</p><p><strong>Methods: </strong>This cross-sectional study was conducted over four months (August 2021- December 2021) and included the general Jordanian population above 18 years old.</p><p><strong>Results: </strong>A total of 398 participants were included in the study, with the majority (around 81.0%) received at least one dose of any of COVID-19 vaccines approved for use in Jordan. Most non-vaccinated participants (67.4%) were either unwilling to receive the COVID-19 vaccine or unsure. The main reasons for receiving the vaccine were: family protection, self-protection, global efforts to fight the virus and local restrictions, with some variability between vaccinated and non-vaccinated. The major reasons for fear of COVID-19 vaccines were limited research, vaccine effectiveness, and vaccine side effects. Pfizer-BioNTech vaccine was the most trusted vaccine by vaccinated and non-vaccinated participants (47.8% and 57.9%, respectively), and Oxford-AstraZeneca was the most feared by them (42.2% and 57.9%, respectively). Internet websites (>85.0%), social media platforms (>70.0%), relatives and friends (>69.0%), and news applications (>60.0%) were the major sources of information about the COVID-19 vaccines among participants.</p><p><strong>Conclusion: </strong>Our results revealed that hesitation in receiving the vaccine remains a challenge in Jordan, as in other countries. The findings also show that participants, regardless of their vaccination status, had many concerns about the four types of vaccines approved for use in Jordan during the study conduction period. Moreover, the participants' perceptions and attitudes towards the vaccines were variable between vaccinated and non-vaccinated participants and were variable for the four types of vaccines.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2781"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/a6/pharmpract-21-2781.PMC10117358.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Psychological effects on self-medication during the pandemic COVID-19 in WP Labuan: A development of questionnaire and pilot-testing. 新冠肺炎大流行期间WP Labuan自我用药的心理影响:问卷调查和试验的发展。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2023-01-25 DOI: 10.18549/PharmPract.2023.1.2779
Michelle L Tan, Shamsur Rahman, Freddie Robinson, Mohd Hijaz Mohd Sani

Introduction: Self-Medication, which is a practice to self-treat using medicine without consulting a medical practitioner or a doctor, is a common practice and the Pandemic Covid-19 may have caused people to resort to self-medication in order to reduce the infectivity of the Covid-19.

Objective: To validate and develop an instrument in Bahasa Melayu to assess the psychological distress and self-medication during pandemic Covid-19 in WP Labuan.

Methods: A pilot study was conducted among 160 participants in WP Labuan. Reliability testing on internal consistency and content validity was performed on the adapted Covid-19 Peritraumatic Distress Index (CPDI) as well as domain on knowledge, practice and attitude of self-medication.

Result: A panel of seven experts evaluated the research instrument for content validity and it was found to have good content item validity. The CPDI domain showed good internal consistency of Cronbach's Alpha of 0.919. The mean (SD) CPDI score of the respondents in WP Labuan was 32.55 (15.98). 64.2% of the respondents experienced psychological distress. The variable for Area (town/countryside) was found to be statistically significant (p<0.05) to be associated with self-medication during the pandemic.

Conclusion: The instrument established sound reliability and validity and therefore, can be an effective tool for assessing psychological distress and self-medication in the Malaysian population.

简介:自我用药,是一种在不咨询医生或医生的情况下使用药物进行自我治疗的做法,是一种常见的做法,新冠肺炎大流行可能导致人们求助于自我药物治疗以降低新冠肺炎的传染性。采用新冠肺炎创伤后痛苦指数(CPDI)对研究工具进行了内部一致性和内容有效性的可靠性测试,并对自我医疗的知识、实践和态度领域进行了测试。结果:由七名专家组成的小组对研究工具的内容有效性进行了评估,发现其具有良好的内容项有效性。CPDI结构域显示出良好的内部一致性,Cronbach’s Alpha为0.919。WP纳闽调查对象的平均(SD)CPDI得分为32.55(15.98)。64.2%的调查对象经历过心理困扰。地区(城镇/乡村)的变量具有统计学意义(P结论:该仪器建立了良好的可靠性和有效性,因此可以成为评估马来西亚人群心理困扰和自我治疗的有效工具。
{"title":"Psychological effects on self-medication during the pandemic COVID-19 in WP Labuan: A development of questionnaire and pilot-testing.","authors":"Michelle L Tan,&nbsp;Shamsur Rahman,&nbsp;Freddie Robinson,&nbsp;Mohd Hijaz Mohd Sani","doi":"10.18549/PharmPract.2023.1.2779","DOIUrl":"10.18549/PharmPract.2023.1.2779","url":null,"abstract":"<p><strong>Introduction: </strong>Self-Medication, which is a practice to self-treat using medicine without consulting a medical practitioner or a doctor, is a common practice and the Pandemic Covid-19 may have caused people to resort to self-medication in order to reduce the infectivity of the Covid-19.</p><p><strong>Objective: </strong>To validate and develop an instrument in Bahasa Melayu to assess the psychological distress and self-medication during pandemic Covid-19 in WP Labuan.</p><p><strong>Methods: </strong>A pilot study was conducted among 160 participants in WP Labuan. Reliability testing on internal consistency and content validity was performed on the adapted Covid-19 Peritraumatic Distress Index (CPDI) as well as domain on knowledge, practice and attitude of self-medication.</p><p><strong>Result: </strong>A panel of seven experts evaluated the research instrument for content validity and it was found to have good content item validity. The CPDI domain showed good internal consistency of Cronbach's Alpha of 0.919. The mean (SD) CPDI score of the respondents in WP Labuan was 32.55 (15.98). 64.2% of the respondents experienced psychological distress. The variable for Area (town/countryside) was found to be statistically significant (p<0.05) to be associated with self-medication during the pandemic.</p><p><strong>Conclusion: </strong>The instrument established sound reliability and validity and therefore, can be an effective tool for assessing psychological distress and self-medication in the Malaysian population.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2779"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b0/02/pharmpract-21-2779.PMC10117300.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756188","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The psychological impact of COVID-19 restrictions on undergraduate students in Jordan. 新冠肺炎限制措施对约旦本科生的心理影响。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2023-01-18 DOI: 10.18549/PharmPract.2023.1.2786
Saif Aldeen Jaber

Introduction: COVID-19 has spread all over the world since December 2019 causing millions of deaths. The pandemic has not only caused a risk of death from the infection but also caused psychological unbearable stress on people due to restrictions.

Methodology: A sample of students from Jordanian different universities using a questionnaire has been conducted. The questionnaire has been prepared with different personal questions to correlate the answers with anger episodes/week.

Results: 750 students participated and indicated that 13.6% and 20.9% of students have been facing severe anger episodes (>2) or moderate anger episodes (1-2) every week. Moreover, stable family income ((OR=0.901, 95%CI = 0.799-0.998), studying at private universities (OR=0.0.724, 95%CI = 0.627-.833) and living in the city centre (OR=0.0.698, 95%CI = 0.492-0.897) have a protective effect on anger episodes. However, student gender and study level have no significant effect on anger severity.

Conclusion: Undergraduate and master's students have faced severe conditions during the Covid-19 lockdown which had a direct psychological effect on them. Students' situations and students' study levels should be taken into consideration to provide a mental health program for whom under huge stress.

简介:自2019年12月以来,新冠肺炎已在全球蔓延,造成数百万人死亡。新冠疫情不仅造成了感染死亡的风险,而且由于限制措施,给人们带来了难以承受的心理压力。方法:对来自约旦不同大学的学生进行了问卷调查。调查问卷采用了不同的个人问题,以将答案与每周的愤怒发作相关联。结果:750名学生参与了调查,表明13.6%和20.9%的学生每周都会面临严重的愤怒发作(>2)或中度的愤怒发作。此外,稳定的家庭收入(OR=0.901,95%CI=0.799-0.998)、在私立大学学习(OR=0.0.724,95%CI=0.627-.833)和住在市中心(OR=0.0.698,95%CI=0.492-0.897)对愤怒发作有保护作用。然而,学生性别和学习水平对愤怒的严重程度没有显著影响。结论:新冠肺炎封锁期间,本科生和硕士生面临着严峻的条件,这对他们产生了直接的心理影响。应考虑学生的情况和学习水平,为压力巨大的学生提供心理健康计划。
{"title":"The psychological impact of COVID-19 restrictions on undergraduate students in Jordan.","authors":"Saif Aldeen Jaber","doi":"10.18549/PharmPract.2023.1.2786","DOIUrl":"10.18549/PharmPract.2023.1.2786","url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 has spread all over the world since December 2019 causing millions of deaths. The pandemic has not only caused a risk of death from the infection but also caused psychological unbearable stress on people due to restrictions.</p><p><strong>Methodology: </strong>A sample of students from Jordanian different universities using a questionnaire has been conducted. The questionnaire has been prepared with different personal questions to correlate the answers with anger episodes/week.</p><p><strong>Results: </strong>750 students participated and indicated that 13.6% and 20.9% of students have been facing severe anger episodes (>2) or moderate anger episodes (1-2) every week. Moreover, stable family income ((OR=0.901, 95%CI = 0.799-0.998), studying at private universities (OR=0.0.724, 95%CI = 0.627-.833) and living in the city centre (OR=0.0.698, 95%CI = 0.492-0.897) have a protective effect on anger episodes. However, student gender and study level have no significant effect on anger severity.</p><p><strong>Conclusion: </strong>Undergraduate and master's students have faced severe conditions during the Covid-19 lockdown which had a direct psychological effect on them. Students' situations and students' study levels should be taken into consideration to provide a mental health program for whom under huge stress.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2786"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/81/pharmpract-21-2786.PMC10117323.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Co-infection of COVID-19 patients with atypical bacteria: A study based in Jordan. 新冠肺炎患者与非典型细菌的共同感染:约旦的一项研究。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-11-09 DOI: 10.18549/PharmPract.2023.1.2753
Ahmad R Alsayed, Luai Hasoun, Heba A Khader, Mahmoud S Abu-Samak, Laith Mh Al-Shdifat, Basheer Al-Shammari, Mohammed Al Maqbali

Objective: The aim of this work was to know the prevalence of Chlamydophila pneumoniae and Mycoplasma pneumoniae in coronavirus disease 2019 (COVID-19) patients in Jordan. Also, to assess a TaqMan real-time polymerase chain reaction (PCR) assay in detecting these two bacteria.

Methods: This is a retrospective study performed over the last five months of the 2021. All nasopharyngeal specimens from COVID-19 patients were tested for C. pneumonia, and M. pneumoniae. The C. pneumoniae Pst-1 gene and M. pneumoniae P1 cytadhesin protein gene were the targets.

Results: In this study, 14 out of 175 individuals with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (8.0%) were co-infected with C. pneumoniae or M. pneumoniae. Co-infection with SARS-CoV-2 and C. pneumoniae was reported in 5 (2.9%) patients, while 9 (5.1%) patients had M. pneumoniae and SARS-CoV-2 co-infection. The mean (± std) of the correlation coefficient of the calibration curve for real-time PCR analysis was -0.993 (± 0.001) for C. pneumoniae and -0.994 (± 0.003) for M. pneumoniae. The mean amplification efficiencies of C. pneumoniae and M. Pneumoniae were 187.62% and 136.86%, respectively.

Conclusion: In this first study based in Jordan, patients infected with COVID-19 have a low rate of atypical bacterial co-infection. However, clinicians should suspect co-infections with both common and uncommon bacteria in COVID-19 patients. Large prospective investigations are needed to give additional insight on the true prevalence of these co-infections and their impact on the clinical course of COVID-19 patients.

目的:了解约旦2019冠状病毒病(新冠肺炎)患者肺炎衣原体和肺炎支原体的流行情况。此外,评估TaqMan实时聚合酶链式反应(PCR)检测这两种细菌的方法。方法:这是一项在2021年最后五个月进行的回顾性研究。对新冠肺炎患者的所有鼻咽标本进行肺炎梭菌和肺炎支原体检测。以肺炎支原体Pst-1基因和肺炎支原体P1细胞粘附素蛋白基因为靶点。结果:在这项研究中,175名确诊感染严重急性呼吸系统综合征冠状病毒2型的患者中有14人(8.0%)同时感染了肺炎链球菌或肺炎支原体。据报道,5名(2.9%)患者同时感染了严重急性呼吸系统综合征冠状病毒2型和肺炎链球菌,9名(5.1%)患者合并感染了肺炎链球菌和严重急性呼吸系冠状病毒2型。用于实时PCR分析的校准曲线的相关系数的平均值(±std)对于肺炎链球菌为-0.993(±0.001),对于肺炎支原体为-0.994(±0.003)。肺炎链球菌和肺炎支原体的平均扩增效率分别为187.62%和136.86%。结论:在这项基于约旦的首次研究中,新冠肺炎感染者的非典型细菌合并感染率较低。然而,临床医生应该怀疑新冠肺炎患者同时感染了常见细菌和罕见细菌。需要进行大型前瞻性调查,以进一步了解这些合并感染的真实流行率及其对新冠肺炎患者临床过程的影响。
{"title":"Co-infection of COVID-19 patients with atypical bacteria: A study based in Jordan.","authors":"Ahmad R Alsayed,&nbsp;Luai Hasoun,&nbsp;Heba A Khader,&nbsp;Mahmoud S Abu-Samak,&nbsp;Laith Mh Al-Shdifat,&nbsp;Basheer Al-Shammari,&nbsp;Mohammed Al Maqbali","doi":"10.18549/PharmPract.2023.1.2753","DOIUrl":"10.18549/PharmPract.2023.1.2753","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this work was to know the prevalence of <i>Chlamydophila pneumoniae</i> and <i>Mycoplasma pneumoniae</i> in coronavirus disease 2019 (COVID-19) patients in Jordan. Also, to assess a TaqMan real-time polymerase chain reaction (PCR) assay in detecting these two bacteria.</p><p><strong>Methods: </strong>This is a retrospective study performed over the last five months of the 2021. All nasopharyngeal specimens from COVID-19 patients were tested for C. pneumonia, and M. pneumoniae. The <i>C. pneumoniae</i> Pst-1 gene and <i>M. pneumoniae</i> P1 cytadhesin protein gene were the targets.</p><p><strong>Results: </strong>In this study, 14 out of 175 individuals with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (8.0%) were co-infected with <i>C. pneumoniae</i> or <i>M. pneumoniae</i>. Co-infection with SARS-CoV-2 and <i>C. pneumoniae</i> was reported in 5 (2.9%) patients, while 9 (5.1%) patients had <i>M. pneumoniae</i> and SARS-CoV-2 co-infection. The mean (± std) of the correlation coefficient of the calibration curve for real-time PCR analysis was -0.993 (± 0.001) for <i>C. pneumoniae</i> and -0.994 (± 0.003) for <i>M. pneumoniae</i>. The mean amplification efficiencies of <i>C. pneumoniae</i> and <i>M. Pneumoniae</i> were 187.62% and 136.86%, respectively.</p><p><strong>Conclusion: </strong>In this first study based in Jordan, patients infected with COVID-19 have a low rate of atypical bacterial co-infection. However, clinicians should suspect co-infections with both common and uncommon bacteria in COVID-19 patients. Large prospective investigations are needed to give additional insight on the true prevalence of these co-infections and their impact on the clinical course of COVID-19 patients.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2753"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ae/0f/pharmpract-21-2753.PMC10117357.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9756194","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae. 通过三种肾功能公式分层的心房颤动患者利伐沙班给药差异的临床相关性。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-12-02 DOI: 10.18549/PharmPract.2023.1.2758
Juhaina Salim Al-Maqbali, Abdullah M Al Alawi, Maria Al-Adawi, Zubaida Al-Falahi, Asia Al-Azizi, Kholoud Al Badi, Mohamed Al Rawahi

Background: Clinical trials used Cockcroft-Gault (CG) formula to calculate the estimated glomerular filtration rate (eGFR) in order to dose rivaroxaban for patients with atrial fibrillation (AF).

Objectives: The aim of this study is to evaluate rivaroxaban dosing appropriateness in patients with AF with or without renal impairment based on the CG formula and other formulae, including Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the isotope dilution mass spectrometry (IDMS) traceable Modification of Diet in Renal Disease (MDRD) Study equation and the associated clinical outcomes.

Methodology: A retrospective cohort study conducted at Sultan Qaboos University Hospital (SQUH) from 1st January 2016 to 31st December 2020, included all adult patients (≥ 18 years) treated with rivaroxaban for AF and followed up for one year after starting the treatment.

Results: Based on the CG formula, the rivaroxaban dose was inappropriately prescribed in 27% of the patients (21% overdosed and 6% underdosed). Higher baseline creatinine (P=0.0014) and concurrent use of antiplatelet therapy (P<0.001) were associated with the tendency to rivaroxaban overdosing. Higher Body Mass Index (BMI) (P=0.002), female sex (P=0.032), and CKD (P=0.003) were associated with rivaroxaban underdosing. The degree of agreement between the renal function tests when comparing MDRD vs CG and CKD-EPI vs CG in terms of estimated glomerular filtration rate/creatine clearance (eGFR/CrCl) calculation was moderate (κ=0.46) and poor (κ=0.00), respectively, while, in terms of rivaroxaban dose appropriateness was almost perfect (κ=0.82) and substantial (κ=0.77). Clinical outcomes measured by stroke and bleeding events were not significantly different according to the appropriateness of the rivaroxaban dose.

Conclusion: This study has shown a relatively high consistency with the gold standard in dosing rivaroxaban in AF patients using CG formula. Treatment efficiency and safety were not affected by the proportion of dose inappropriateness found in this cohort.

背景:临床试验使用Cockcroft-Gault(CG)公式计算估计的肾小球滤过率(eGFR),以给心房颤动(AF)患者服用利伐沙班,包括慢性肾脏疾病流行病学协作(CKD-EPI)方程和同位素稀释质谱(IDMS)可追踪的肾脏疾病饮食改良(MDRD)研究方程及其相关临床结果。方法:2016年1月1日至2020年12月31日在苏丹卡布斯大学医院(SQUH)进行的一项回顾性队列研究,包括所有接受利伐沙班房颤治疗的成年患者(≥18岁),并在开始治疗后随访一年。结果:根据CG公式,27%的患者(21%服用过量,6%服用不足)的利伐沙班剂量不适当。较高的基线肌酸酐(P=0.0014)和同时使用抗血小板治疗(P结论:本研究表明,使用CG配方奶粉给AF患者服用利伐沙班与金标准的一致性相对较高。该队列中发现的剂量不当比例不影响治疗效率和安全性。
{"title":"Clinical Associations with the differences in rivaroxaban dosing in patients with atrial fibrillation stratified by three renal function formulae.","authors":"Juhaina Salim Al-Maqbali,&nbsp;Abdullah M Al Alawi,&nbsp;Maria Al-Adawi,&nbsp;Zubaida Al-Falahi,&nbsp;Asia Al-Azizi,&nbsp;Kholoud Al Badi,&nbsp;Mohamed Al Rawahi","doi":"10.18549/PharmPract.2023.1.2758","DOIUrl":"10.18549/PharmPract.2023.1.2758","url":null,"abstract":"<p><strong>Background: </strong>Clinical trials used Cockcroft-Gault (CG) formula to calculate the estimated glomerular filtration rate (eGFR) in order to dose rivaroxaban for patients with atrial fibrillation (AF).</p><p><strong>Objectives: </strong>The aim of this study is to evaluate rivaroxaban dosing appropriateness in patients with AF with or without renal impairment based on the CG formula and other formulae, including Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation and the isotope dilution mass spectrometry (IDMS) traceable Modification of Diet in Renal Disease (MDRD) Study equation and the associated clinical outcomes.</p><p><strong>Methodology: </strong>A retrospective cohort study conducted at Sultan Qaboos University Hospital (SQUH) from 1st January 2016 to 31st December 2020, included all adult patients (≥ 18 years) treated with rivaroxaban for AF and followed up for one year after starting the treatment.</p><p><strong>Results: </strong>Based on the CG formula, the rivaroxaban dose was inappropriately prescribed in 27% of the patients (21% overdosed and 6% underdosed). Higher baseline creatinine (P=0.0014) and concurrent use of antiplatelet therapy (P<0.001) were associated with the tendency to rivaroxaban overdosing. Higher Body Mass Index (BMI) (P=0.002), female sex (P=0.032), and CKD (P=0.003) were associated with rivaroxaban underdosing. The degree of agreement between the renal function tests when comparing MDRD vs CG and CKD-EPI vs CG in terms of estimated glomerular filtration rate/creatine clearance (eGFR/CrCl) calculation was moderate (κ=0.46) and poor (κ=0.00), respectively, while, in terms of rivaroxaban dose appropriateness was almost perfect (κ=0.82) and substantial (κ=0.77). Clinical outcomes measured by stroke and bleeding events were not significantly different according to the appropriateness of the rivaroxaban dose.</p><p><strong>Conclusion: </strong>This study has shown a relatively high consistency with the gold standard in dosing rivaroxaban in AF patients using CG formula. Treatment efficiency and safety were not affected by the proportion of dose inappropriateness found in this cohort.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2758"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/b1/pharmpract-21-2758.PMC10117315.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9387594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The socio-demographic and lifestyle characteristics associated with quality of life among diabetic patients in Lebanon: a cross-sectional study. 黎巴嫩糖尿病患者与生活质量相关的社会人口统计学和生活方式特征:一项横断面研究。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2023-01-01 Epub Date: 2022-12-21 DOI: 10.18549/PharmPract.2023.1.2775
Diana Dakroub, Fouad Sakr, Mariam Dabbous, Nada Dia, Jana Hammoud, Aya Rida, Aya Ibrahim, Hala Fahs, Sahar Obeid, Souheil Hallit, Diana Malaeb

Objective: Diabetes mellitus (DM) is a chronic non-communicable endocrine disease that has a considerable impact on both the health and quality of life (QoL) of patients. This study aimed to investigate the sociodemographic factors associated with the quality of life among the Lebanese population with DM.

Methods: A cross-sectional study that enrolled 125 diabetic patients aged ≥18, was conducted between January and June of 2021. The validated Arabic version of the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire is utilized by all patients to measure the quality of life (QoL). A logistic regression was then performed.

Results: The life domains "freedom to eat" and "freedom to drink", were the most negatively impacted by diabetes. According to the multivariate analysis monthly income OR 3.4, 95 % CIs 1.25 -9.6, P = 0.017, educational level (OR) 0.2, 95 % CIs 0.07 -0.89, HbA1c (OR) 7, 95 % CIs 1.5 -32.35, and FBG [odds ratio (OR) 1.01, 95 % (CIs) 1.004 -1.021, P = 0.005] were independently associated with impaired QOL.

Conclusion: The study showed that diabetes generally had a negative impact on QoL. The findings also suggest that certain sociodemographic factors, such as monthly income and educational level along with clinical parameters like HbA1c, might be associated with a lower quality of life among Lebanese diabetic patients.

目的:糖尿病(DM)是一种慢性非传染性内分泌疾病,对患者的健康和生活质量有很大影响。本研究旨在调查与黎巴嫩糖尿病患者生活质量相关的社会人口学因素。方法:2021年1月至6月,对125名年龄≥18岁的糖尿病患者进行了横断面研究。所有患者都使用经验证的阿拉伯语版糖尿病依赖性生活质量审计问卷(ADDQoL)来衡量生活质量。然后进行逻辑回归。结果:糖尿病对生活领域“饮食自由”和“饮酒自由”的负面影响最大。根据多变量分析,月收入OR 3.4,95%CI 1.25-9.6,P=0.017,教育水平(OR)0.2,95%CI 0.07-0.89,HbA1c(OR)7,95%CI 1.5-32.35,FBG[比值比(OR)1.01,95%(CI)1.004-1.021,P=0.005]与生活质量受损独立相关。结论:研究表明,糖尿病通常对生活质量产生负面影响。研究结果还表明,某些社会人口因素,如月收入和教育水平,以及HbA1c等临床参数,可能与黎巴嫩糖尿病患者的生活质量较低有关。
{"title":"The socio-demographic and lifestyle characteristics associated with quality of life among diabetic patients in Lebanon: a cross-sectional study.","authors":"Diana Dakroub,&nbsp;Fouad Sakr,&nbsp;Mariam Dabbous,&nbsp;Nada Dia,&nbsp;Jana Hammoud,&nbsp;Aya Rida,&nbsp;Aya Ibrahim,&nbsp;Hala Fahs,&nbsp;Sahar Obeid,&nbsp;Souheil Hallit,&nbsp;Diana Malaeb","doi":"10.18549/PharmPract.2023.1.2775","DOIUrl":"10.18549/PharmPract.2023.1.2775","url":null,"abstract":"<p><strong>Objective: </strong>Diabetes mellitus (DM) is a chronic non-communicable endocrine disease that has a considerable impact on both the health and quality of life (QoL) of patients. This study aimed to investigate the sociodemographic factors associated with the quality of life among the Lebanese population with DM.</p><p><strong>Methods: </strong>A cross-sectional study that enrolled 125 diabetic patients aged ≥18, was conducted between January and June of 2021. The validated Arabic version of the Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire is utilized by all patients to measure the quality of life (QoL). A logistic regression was then performed.</p><p><strong>Results: </strong>The life domains \"freedom to eat\" and \"freedom to drink\", were the most negatively impacted by diabetes. According to the multivariate analysis monthly income OR 3.4, 95 % CIs 1.25 -9.6, P = 0.017, educational level (OR) 0.2, 95 % CIs 0.07 -0.89, HbA1c (OR) 7, 95 % CIs 1.5 -32.35, and FBG [odds ratio (OR) 1.01, 95 % (CIs) 1.004 -1.021, P = 0.005] were independently associated with impaired QOL.</p><p><strong>Conclusion: </strong>The study showed that diabetes generally had a negative impact on QoL. The findings also suggest that certain sociodemographic factors, such as monthly income and educational level along with clinical parameters like HbA1c, might be associated with a lower quality of life among Lebanese diabetic patients.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"21 1","pages":"2775"},"PeriodicalIF":2.5,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/59/8b/pharmpract-21-2775.PMC10117344.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9444366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia. 印尼一所二级教学医院急诊科老年人的患病率和潜在不适当药物的相关因素以及药物复杂性。
IF 2.5 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2022-10-01 Epub Date: 2022-11-08 DOI: 10.18549/PharmPract.2022.4.2735
Khusnul Fitri Hamidah, Mahardian Rahmadi, Farah Meutia, Prihatma Kriswidyatomo, Firman Suryadi Rahman, Zamrotul Izzah, Bambang Subakti Zulkarnain, Leopold N Aminde, Christopher Paul Alderman, Yulistiani, Budi Suprapti

Background: Older adults experience progressive decline in various organs and changes in pharmacokinetics and pharmacodynamics of the drugs in the body which lead to an increased risk of medication-related problems. Potentially inappropriate medications (PIMs) and medication complexity are key factors contributing to adverse drug events in the emergency department (ED).

Objective: To estimate the prevalence and investigate the risk factors of PIMs and medication complexity among older adults admitted to the ED.

Methods: A retrospective observational study was conducted among patients aged > 60 years admitted to the ED of Universitas Airlangga Teaching Hospital in January - June 2020. PIMs and medication complexity were measured using the 2019 American Geriatrics Society Beers Criteria® and Medication Regimen Complexity Index (MRCI), respectively.

Results: A total of 1005 patients were included and 55.0% (95% confidence interval [CI]: 52 - 58%) of them received at least one PIM. Whereas, the pharmacological therapy prescribed to older adults had a high complexity index (mean MRCI 17.23 + 11.15). Multivariate analysis showed that those with polypharmacy (OR= 6.954; 95% CI: 4.617 - 10.476), diseases of the circulatory system (OR= 2.126; 95% CI: 1.166 - 3.876), endocrine, nutritional, and metabolic diseases (OR= 1.924; 95% CI: 1.087 - 3.405), and diseases of the digestive system (OR= 1.858; 95% CI: 1.214 - 2.842) had an increased risk of receiving PIM prescriptions. Meanwhile, disease of the respiratory system (OR = 7.621; 95% CI: 2.833 - 15.150), endocrine, nutritional and metabolic diseases (OR = 6.601; 95% CI: 2.935 - 14.847), and polypharmacy (OR = 4.373; 95% CI: 3.540 - 5.401) were associated with higher medication complexity.

Conclusion: In our study, over one in every two older adults admitted to the ED had PIMs, and a high medication complexity was observed. Endocrine, nutritional and metabolic disease was the leading risk factors for receiving PIMs and high medication complexity.

背景:老年人的各种器官逐渐衰退,体内药物的药代动力学和药效学发生变化,导致药物相关问题的风险增加。潜在的不适当药物(PIM)和药物复杂性是导致急诊科(ED)药物不良事件的关键因素。目的:评估住院老年人PIM的患病率,并调查PIM的危险因素和药物复杂性。方法:对2020年1-6月入住艾尔朗加大学教学医院急诊室的年龄>60岁的患者进行回顾性观察研究。PIM和药物复杂性分别使用2019年美国老年医学会Beers标准®和药物方案复杂性指数(MRCI)进行测量。结果:共纳入1005名患者,其中55.0%(95%置信区间[CI]:52-58%)的患者至少接受了一次PIM。然而,老年人的药物治疗具有较高的复杂性指数(平均MRCI 17.23+1.115)。多因素分析显示,多药治疗(OR=6.954;95%CI:4.617-10.476)、循环系统疾病(OR=2.126;95%CI:1.16 6-3.876)、内分泌、营养和代谢疾病(OR=1.924;95%CI:1.087-3.405),消化系统疾病(OR=1.858;95%CI:1.214-2.842)接受PIM处方的风险增加。同时,呼吸系统疾病(OR=7.621;95%CI:2.833-15.150)、内分泌、营养和代谢疾病(OR=6.601;95%CI:2.935-14.847)和多药治疗(OR=4.373;95%CI:3.540-5.401)与较高的药物复杂性相关。结论:在我们的研究中,每两名入住急诊室的老年人中就有一人患有PIM,并且观察到药物的复杂性很高。内分泌、营养和代谢疾病是接受PIM和药物复杂性高的主要风险因素。
{"title":"Prevalence and factors associated with potentially inappropriate medication and medication complexity for older adults in the emergency department of a secondary teaching hospital in Indonesia.","authors":"Khusnul Fitri Hamidah,&nbsp;Mahardian Rahmadi,&nbsp;Farah Meutia,&nbsp;Prihatma Kriswidyatomo,&nbsp;Firman Suryadi Rahman,&nbsp;Zamrotul Izzah,&nbsp;Bambang Subakti Zulkarnain,&nbsp;Leopold N Aminde,&nbsp;Christopher Paul Alderman,&nbsp;Yulistiani,&nbsp;Budi Suprapti","doi":"10.18549/PharmPract.2022.4.2735","DOIUrl":"10.18549/PharmPract.2022.4.2735","url":null,"abstract":"<p><strong>Background: </strong>Older adults experience progressive decline in various organs and changes in pharmacokinetics and pharmacodynamics of the drugs in the body which lead to an increased risk of medication-related problems. Potentially inappropriate medications (PIMs) and medication complexity are key factors contributing to adverse drug events in the emergency department (ED).</p><p><strong>Objective: </strong>To estimate the prevalence and investigate the risk factors of PIMs and medication complexity among older adults admitted to the ED.</p><p><strong>Methods: </strong>A retrospective observational study was conducted among patients aged > 60 years admitted to the ED of Universitas Airlangga Teaching Hospital in January - June 2020. PIMs and medication complexity were measured using the 2019 American Geriatrics Society Beers Criteria® and Medication Regimen Complexity Index (MRCI), respectively.</p><p><strong>Results: </strong>A total of 1005 patients were included and 55.0% (95% confidence interval [CI]: 52 - 58%) of them received at least one PIM. Whereas, the pharmacological therapy prescribed to older adults had a high complexity index (mean MRCI 17.23 + 11.15). Multivariate analysis showed that those with polypharmacy (OR= 6.954; 95% CI: 4.617 - 10.476), diseases of the circulatory system (OR= 2.126; 95% CI: 1.166 - 3.876), endocrine, nutritional, and metabolic diseases (OR= 1.924; 95% CI: 1.087 - 3.405), and diseases of the digestive system (OR= 1.858; 95% CI: 1.214 - 2.842) had an increased risk of receiving PIM prescriptions. Meanwhile, disease of the respiratory system (OR = 7.621; 95% CI: 2.833 - 15.150), endocrine, nutritional and metabolic diseases (OR = 6.601; 95% CI: 2.935 - 14.847), and polypharmacy (OR = 4.373; 95% CI: 3.540 - 5.401) were associated with higher medication complexity.</p><p><strong>Conclusion: </strong>In our study, over one in every two older adults admitted to the ED had PIMs, and a high medication complexity was observed. Endocrine, nutritional and metabolic disease was the leading risk factors for receiving PIMs and high medication complexity.</p>","PeriodicalId":51762,"journal":{"name":"Pharmacy Practice-Granada","volume":"20 4","pages":"2735"},"PeriodicalIF":2.5,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f2/8a/pharmpract-20-2735.PMC9891774.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10795145","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Pharmacy Practice-Granada
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1